At present, studies have shown that KLF6 silencing in ovarian cancer can promote cell and tumor growth and blood vessel production, but whether it can promote apoptosis of ovarian cancer has yet to be further studied (DiFeo et al., 2006; Han and Gong, 2021; Zhang et al., 2021). The gene discussed is KLF6; the disease is ovarian carcinoma.